This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Jul 14;314(2):127-8.

doi: 10.1001/jama.2015.7434.

Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom

Philip Greenland¹, Michael S Lauer²

Affiliations

Affiliations

¹ Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois2Senior Editor, JAMA.
² Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

PMID: 26172891
DOI: 10.1001/jama.2015.7434

Editorial

Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom

Philip Greenland et al. JAMA. 2015.

. 2015 Jul 14;314(2):127-8.

doi: 10.1001/jama.2015.7434.

Authors

Philip Greenland¹, Michael S Lauer²

Affiliations

¹ Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois2Senior Editor, JAMA.
² Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

PMID: 26172891
DOI: 10.1001/jama.2015.7434

No abstract available

PubMed Disclaimer

Comment on

Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U. Pursnani A, et al. JAMA. 2015 Jul 14;314(2):134-41. doi: 10.1001/jama.2015.7515. JAMA. 2015. PMID: 26172893 Free PMC article.
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
Pandya A, Sy S, Cho S, Weinstein MC, Gaziano TA. Pandya A, et al. JAMA. 2015 Jul 14;314(2):142-50. doi: 10.1001/jama.2015.6822. JAMA. 2015. PMID: 26172894 Free PMC article.

Similar articles

Use of controversial ACC/AHA guidelines for statin therapy is supported by US studies.
McCarthy M. McCarthy M. BMJ. 2015 Jul 19;351:h3902. doi: 10.1136/bmj.h3902. BMJ. 2015. PMID: 26194997 No abstract available.
Predicted vs Observed Clinical Event Risk for Cardiovascular Disease.
DeFilippis AP, Blaha MJ. DeFilippis AP, et al. JAMA. 2015 Nov 17;314(19):2082. doi: 10.1001/jama.2015.12916. JAMA. 2015. PMID: 26575067 No abstract available.
Predicted vs Observed Clinical Event Risk for Cardiovascular Disease-Reply.
Pursnani A, Massaro JM, Hoffmann U. Pursnani A, et al. JAMA. 2015 Nov 17;314(19):2082-3. doi: 10.1001/jama.2015.12931. JAMA. 2015. PMID: 26575068 Free PMC article. No abstract available.
Drugs for lipids.
[No authors listed] [No authors listed] Treat Guidel Med Lett. 2011 Mar;9(103):13-20. Treat Guidel Med Lett. 2011. PMID: 21350395 Review. No abstract available.
A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines.
Kelly SC, Gonzalo R, Petrasko M. Kelly SC, et al. S D Med. 2014 Aug;67(8):320-3. S D Med. 2014. PMID: 25163226 Review. No abstract available.

See all similar articles

Cited by

Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials.
Johnson D, Hughes D, Pirmohamed M, Jorgensen A. Johnson D, et al. J Pers Med. 2019 Sep 1;9(3):42. doi: 10.3390/jpm9030042. J Pers Med. 2019. PMID: 31480618 Free PMC article. Review.
EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.
Selker HP, Gorman S, Kaitin KI. Selker HP, et al. Trans Am Clin Climatol Assoc. 2018;129:279-300. Trans Am Clin Climatol Assoc. 2018. PMID: 30166723 Free PMC article.
Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach.
Bonek K, Głuszko P. Bonek K, et al. Reumatologia. 2016;54(3):128-35. doi: 10.5114/reum.2016.61214. Epub 2016 Jul 18. Reumatologia. 2016. PMID: 27504023 Free PMC article. Review.
Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study.
Galper BZ, Wang YC, Einstein AJ. Galper BZ, et al. PLoS One. 2015 Sep 30;10(9):e0138092. doi: 10.1371/journal.pone.0138092. eCollection 2015. PLoS One. 2015. PMID: 26422204 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information